Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Cytotoxic diarylheptanoid suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 2/March/2014, 17.42

Therapeutic Insights into Metastasis suppression: Cytotoxic diarylheptanoid increases the expression of metastasis suppressor SHARP1 via up regulation of its target gene, 2/March/2014, 17.38
March 2, 2014
Tumorigenesis: MiRNA-494 decreases the expression of p53 homologue TA-p73β via down regulation of its target gene, 2/March/2014, 17.56
March 2, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Cytotoxic diarylheptanoid suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 2/March/2014, 17.42,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.